Chinese english Germany Japanese Korea

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Struktur
853029-57-9
CAS-Nr.
853029-57-9
Englisch Name:
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
Synonyma:
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-butin-1-yl)-8-broMoxanthine;8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione;1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine;Linaint-H;Linagliptin-1;8-Bromo-7-but;LIP-1A IMPURITY;Linagliptin Impurity 32;Linagliptin Impurity 94
CBNumber:
CB72535826
Summenformel:
C20H17BrN6O2
Molgewicht:
453.29
MOL-Datei:
853029-57-9.mol
Request For Quotation

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Eigenschaften

Schmelzpunkt:
>255°C (dec.)
Siedepunkt:
602.9±65.0 °C(Predicted)
Dichte
1.55
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
Löslichkeit
DMSO (Slightly, Heated, Sonicated), Methanol (Very Slightly, Heated, Sonicated)
pka
2.34±0.50(Predicted)
Aggregatzustand
Solid
Farbe
White to Pale Yellow

Sicherheit

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 276)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Frapp's ChemicalNFTZ Co., Ltd. 		+86 (576) 8169-6106
sales@frappschem.com China 885 50
Capot Chemical Co.,Ltd. 		571-85586718 +8613336195806
 sales@capotchem.com China 29797 60
Shanghai Daken Advanced Materials Co.,Ltd 		+86-371-66670886
info@dakenam.com China 15928 58
Beijing Cooperate Pharmaceutical Co.,Ltd 		010-60279497
sales01@cooperate-pharm.com CHINA 1811 55
Henan Tianfu Chemical Co.,Ltd. 		+86-0371-55170693 +86-19937530512
 info@tianfuchem.com China 21691 55
Shanghai Yingrui Biopharma Co., Ltd. 		+86-21-33585366 - 03@
sales03@shyrchem.com CHINA 738 60
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32480 60
Anqing Chico Pharmaceutical Co., Ltd. 		15380796838
chloewu@chicopharm.cn CHINA 341 58
career henan chemical co 		+86-0371-86658258
sales@coreychem.com China 29914 58
Jinan Shengqi pharmaceutical Co,Ltd 		86+18663751872
christine@shengqipharm.com CHINA 491 58
  • 8-BroMo-7-(2-butyn-a-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dione
  • 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dion
  • 8-BroMo-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione
  • 1H-Purine-2,6-dione,8-broMo-7-(2-butynyl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-
  • Linagliptin interMediate F
  • 1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
  • Iinagliptin Intermediate3
  • 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-d
  • 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
  • 8-BroMo-7-but-2-ynyl-3-Methyl-1-(4-Methyquinazolin-2-ylMethyl)-3,7-dihydro-purine-2,6-dione
  • 8-broMo-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione
  • 8-bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
  • Linagliptinmothernucleus
  • Linaint-H
  • Linagliptin Impurity 32
  • 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
  • Linagliptin-1
  • 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)
  • 8-bromo-7-(2-butyne)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-xanthine
  • Linagliptin IntermediateLinagliptin Intermediate
  • 8-BROMO-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE 853029-57-9
  • 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione ISO 9001：2015 REACH
  • (2-(chloromethyl)-4-methylquinazoline)，8-Bromo-7-but-2-ynyl-3-methyl-1-(4- methyl-quinazolin-2-ylmethyl)-3,7- dihydro-purine-2,6-dione
  • Linagliptin Impurity 94
  • 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl...
  • 1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-butin-1-yl)-8-broMoxanthine
  • 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
  • 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
  • 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
  • 8-Bromo-7-(2-Butyn-1-Yl)-3,7-Dihydro-3-Methyl-1-[(4-Methyl-2-Quinazolinyl)Methyl]-1H-Purine-2,6-Dione / Linagliptin Intermediate
  • 1H-Imidazole-4-carboxaldehyde,8-methyl-
  • 8- bromo -7-(2- butyn -1- yl) -3,7- dihydro -3- methyl -1-[(4- methyl -2- quinazolinyl) methyl ]-1H- purin -2,6- dione
  • 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl) 8-bromoyanthine
  • LIP-1A IMPURITY
  • 8-brom-7- (2-butynyl-1-yl) -3,7-dihydro-3-methyl-1- [(4-methyl-2-quinazolino) methyl] -1H-purine-2,6-dione
  • Linagliptin intermediate 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
  • 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dion
  • Linagliptin Related Compound-11 (Bromo compound)
  • 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-xanthine
  • 8-Bromo-7-but
  • 853029-57-9
  • C20H17BrN6O2
  • Intermediates
  • 853029-57-9
Copyright 2019 © ChemicalBook. All rights reserved